Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Replimune Inc.
Scientific Title
A Randomized, Controlled, Open-Label, Phase 2 Study of Cemiplimab as a Single Agent and in Combination With RP1 in Patients With Advanced Cutaneous Squamous Cell Carcinoma